Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification

@inproceedings{Hagen2017ThrombogenicityOF,
  title={Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification},
  author={Matthew W Hagen and Gaurav Girdhar and John Michael Wainwright and Monica T. Hinds},
  booktitle={Journal of neurointerventional surgery},
  year={2017}
}
BACKGROUND Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the Pipeline Embolization Device (PED) flow diverter, which has shown significant reductions in material thrombogenicity in vitro. OBJECTIVE To compare the thrombogenicity of PED, PED with Shield Technology (PED+Shield), and the Flow-Redirection… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 7 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Flow Diversion after Aneurysmal Subarachnoid Hemorrhage.

Neurosurgery clinics of North America • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Initial experience with implantation of novel dual layer flow-diverter device FRED

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques • 2013